← All diseases
Cancer
Prostate cancer (metastatic)
Do you want to receive a message if there is new research about Prostate cancer (metastatic)? This is possible with an account. Create a free account or log in.
Automatically tracked from PubMed and ClinicalTrials.gov, newest on top. Nothing ever disappears here: what you keep in your favorites remains findable. · RSS feed of this disease · only the strongest evidence
Read in plain language what each study is about? With Premium, above each publication you'll find one sentence explaining what was studied — and you'll be notified as soon as there is new research on Prostate cancer (metastatic). View what Premium costs.
Publications and studies (2069)
- Genomic Testing Uptake Among Medicare Beneficiaries With Cancer. (2026/07/01) ♡
- Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. [The diagnostic complexity of paraneoplastic thrombotic thrombocytopenic purpura]. (2026/07/01) ♡
- Commentary or editorialiAn expert's opinion or commentary, not new research. Abiraterone or Enzalutamide in Metastatic Castration-Sensitive Prostate Cancer: Has the Veterans Affairs Corporate Data Warehouse Spoken? (2026/07/01) ♡
- Randomized researchiParticipants were divided into groups by lottery and compared with each other. This reduces the chance that a difference is due to something other than the treatment. Diet and Physical Activity as Mediators of Weight Loss in a Digital Prostate Cancer Survivorship Intervention for Men: Secondary Analysis of the PC-PEP Randomized Trial. (2026/07/01) ♡
- A plasma proteomic signature of cancer-related sarcopenia implicates the IGFBP axis in muscle dysfunction. (2026/06/29) ♡
- Reduced Length of ADT and ARTA With XRT in High-Risk Prostate Cancer (RELAX): A Randomised Controlled Trial. (2026/06/27) ♡
- Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. Prostate Cancer Associated with Muir-Torre Syndrome: A Rare Case Report and Literature Review. (2026/06/23) ♡
- Darolutamide versus abiraterone acetate-based triplets in patients with hormone-sensitive prostate cancer: real-world, head-to-head comparison from the ARON-3 study. (2026/06/23) ♡
- Jaboticaba peel extract limits castration-resistant prostate cancer aggressiveness by counteracting EMT through steroid hormone and TGF-β signaling modulation. (2026/06/22) ♡
- Genomic Determinants of Lethality and Therapeutic Vulnerability in Castration-Resistant Prostate Cancer. (2026/06/20) ♡
- Elevated allostatic load, adverse body composition, and reduced overall survival in a retrospective cohort of men with newly diagnosed metastatic prostate cancer. (2026/06/18) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Metabolic vulnerabilities in advanced prostate cancer: the interplay of ferroptosis, cuproptosis, and the inflammatory microenvironment. (2026/06/12) ♡
- Balancing Stability and Payload Release in Glutathione-Responsive PROTAC Prodrugs Targeting Prostate Cancer. (2026/06/10) ♡
- Adrenal-derived factors drive progression of sclerotic prostate cancer in bone. (2026/06/09) ♡
- Quantifying the Impact of Biochemical Recurrence After Radical Prostatectomy on Overall Mortality by Years of Life Lost: Results from the SEARCH Database. (2026/06/01) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Development of Antibody and Antibody Fragment-Based Radiopharmaceuticals for Cancer Imaging and Therapy. (2026/06/01) ♡
- Exploring the Skeletal Impact: Androgen Deprivation Therapy and Bone Health in Metastatic Prostate Carcinoma Patients. (2026/06/01) ♡
- Lipid Metabolic Rewiring During Continuous Prostate Cancer Progression Defines a Biologically Relevant Four-Gene Prognostic Signature. (2026/05/25) ♡
- Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. Integrative oncology along with systemic cancer therapies in advanced bladder and prostate cancer: metabolic optimization guiding the shift from palliative care to clinical remission - a case report. (2026/05/18) ♡
- Evaluating the knowledge and practices of prostate cancer dietary risk reduction in occupational drivers. (2026/05/11) ♡
- Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. Efficacy of preventive skin moisturization for dermatological adverse events caused by apalutamide: A retrospective study at 2 facilities in Japan. (2026/05/08) ♡
- Neighborhood geographic disparities in colorectal, prostate, breast, and lung cancer risk in Alabama. (2026/05/02) ♡
- Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. First-in-Human Combination of Lead-212-Labeled PSMA Radioligand Therapy and Metabotropic Glutamate Receptor Inhibitor Riluzole as Radiosensitizer in Metastatic Castration-resistant Prostate Cancer. (2026/05/01) ♡
- Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. ProHealth: a co-designed online home-based healthy eating and exercise programme for men with prostate cancer treated with androgen deprivation therapy - a study protocol for a feasibility and preliminary efficacy randomised controlled trial. (2026/04/21) ♡
- Complementary and alternative medicine use among elderly cancer patients: a cross-sectional study in South Korea. (2026/04/15) ♡
- The prognostic value of the CALLY index in patients with metastatic hormone-sensitive prostate cancer. (2026/04/11) ♡
- Broad-spectrum anticancer properties, DFT calculations and macromolecular binding potential of a novel thiolato-bridged fac-Mn(CO)(3)-core-based CO-releasing molecule. (2026/04/05) ♡
- Modified monitoring of abiraterone acetate-induced hepatotoxicity in prostate cancer patients. (2026/04/01) ♡
- Corrigendum to "Treatment Trajectories in Metastatic Hormone-sensitive Prostate Cancer: A PIONEER+ Big Data Analysis" [Eur. Urol. Oncol. 8(5) (2025) 1340-1349]. (2026/04/01) ♡
- Systematic reviewiAll research on one question is searched according to fixed rules and compared side by side, so that no studies with poor outcomes are missed. Effect of Postdiagnosis Diet and Lifestyle on Clinical Outcomes in Prostate Cancer Survivors: A Systematic Review. (2026/04/01) ♡
- Cardiac Function and Prostate Cancer Risk and Prognosis: The PROCA-Life Study. (2026/04/01) ♡
- Metabolomics, network pharmacology, and molecular docking guided discrimination of constituents in four varieties of luohan guo (Siraitia grosvenorii): an assessment of core active ingredients and their potential antioxidant mechanisms. (2026/03/30) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Precision-Engineered CD3 T-Cell Engagers for Solid Tumours: Conditional Activation, Microenvironment Modulation, and Clinical Translation. (2026/03/27) ♡
- Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. A Culturally Tailored Mobile Health Intervention to Improve Quality of Life in Black Survivors With Prostate Cancer: Protocol for a Stratified Randomized Controlled Trial. (2026/03/24) ♡
- Transcatheter aortic valve replacement in patients with cancer: A 10-year registry analysis of early and long-term mortality outcomes. (2026/03/15) ♡
- Randomized researchiParticipants were divided into groups by lottery and compared with each other. This reduces the chance that a difference is due to something other than the treatment. A randomized phase II trial of gemcitabine, nab-paclitaxel, cisplatin with or without a medically supervised ketogenic diet for patients with metastatic pancreatic cancer. (2026/03/15) ♡
- Preferences of healthcare providers regarding future follow-up care for breast, prostate, and colorectal cancer: A discrete choice experiment. (2026/03/15) ♡
- Meta-analysisiAll studies on one question combined and calculated together. This is the strongest form of research that exists: a single loose study can be coincidence, dozens together much less so. The label says something about the design, not about the outcome — which can also be that something does NOT work. [Comorbidities affecting abiraterone treatment in patients with metastatic castration-resistant prostate cancer: a meta-analysis]. (2026/03/12) ♡
- Randomized researchiParticipants were divided into groups by lottery and compared with each other. This reduces the chance that a difference is due to something other than the treatment. Two Versus Five-Fraction Magnetic Resonance-Guided Adaptive Radiotherapy with DOminant-TArgeted Boost in Localized Prostate Cancer (DOTA-2): Interim Acute Toxicity Analysis of the Phase II Randomised Trial. (2026/03/01) ♡
- Metastatic Prostate Cancer with Low-Volume Primary Tumors - A National Cancer Database Analysis on Metastasis Profile and Survival Outcomes. (2026/03/01) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Integral Approach in the Follow-up of Prostate Cancer Patients: SOGUG Multidisciplinary Expert Panel Insights. (2026/03/01) ♡
- Irreversible electroporation for localized prostate cancer: risk-stratified oncologic outcomes and functional preservation. (2026/03/01) ♡
- AR-V7 expression in primary non-metastatic prostate cancer and its role in disease progression following initial therapy: a systematic review and meta-analysis. (2026/03/01) ♡
- Randomized researchiParticipants were divided into groups by lottery and compared with each other. This reduces the chance that a difference is due to something other than the treatment. High-dose vitamin D supplementation and prostate cancer progression: a phase II randomised trial in localised prostate cancer cases with intermediate risk of progression (ProsD). (2026/03/01) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. [Optimizing management of metastatic castration-sensitive prostate cancer: From therapeutic advances to personalized care]. (2026/03/01) ♡
- A Pilot Feasibility Study of a Group-Based Remote-Delivered Dyadic Exercise Intervention in Hispanic Men With Prostate Cancer and Their Caregivers. (2026/03/01) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Therapeutic potential of cytokine-induced killer cell therapy for renal cell carcinoma and prostate cancer. (2026/02/28) ♡
- Real-World Outcomes of Combination Therapy With Radium-223 and Enzalutamide Compared With Enzalutamide Alone in Patients With Metastatic Castration-Resistant Prostate Cancer. (2026/02/25) ♡
- Associations Between Nutritional Status, Sleep Quality, and Clinical Factors in Patients With Metastatic Prostate Cancer. (2026/02/18) ♡
- Anti-metastatic and anti-tumor effects of the ethyl acetate fraction of Ajwa dates (Phoenix dactylifera L.) in prostate cancer models and its UPLC-based phytochemical profiling. (2026/02/10) ♡
codex.care does not provide medical advice. Always discuss symptoms, medication, and treatment choices with your own healthcare provider.